Available-for-sale financial assets comprised the Group's holding
of Novo Nordisk B stock, which was acquired with a view to hedge the stock
option obligation, cf. Note 24.
A gain on stock of DKK 29 million has been transferred from Other
comprehensive income to Financial income relating to the realization. In 2008
the market value adjustment was a loss of DKK 15 million, and DKK 38 million
was transferred to Financial income.